THE LEUKOCYTE INTEGRIN LFA-1 RECONSTITUTED BY CDNA TRANSFECTION IN A NONHEMATOPOIETIC CELL-LINE IS FUNCTIONALLY ACTIVE AND NOT TRANSIENTLY REGULATED

被引:69
作者
LARSON, RS [1 ]
HIBBS, ML [1 ]
SPRINGER, TA [1 ]
机构
[1] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
来源
CELL REGULATION | 1990年 / 1卷 / 04期
关键词
D O I
10.1091/mbc.1.4.359
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The functional activity of lymphocyte function-associated antigen 1 (LFA-1) on leukocytes can be regulated by T-cell receptor (TCR) stimulation and pharmacologic agents. It was of interest to determine if functionally active LFA-1 could be reconstituted on a nonhematopoietic, LFA-1-negative cell line. We report the expression of LFA-1 and diethylaminoethyl (DEAE) Mac-1 αβ heterodimers on the cell surface of a fibroblastoid cell line, COS, by DEAE dextran cotransfection of the α and β subunit cDNAs. Immunoprecipitation studies demonstrated that the α and β subunits were associated in heterodimers. The α or β subunit was expressed at lower levels after transfection with the α or β subunit cDNA alone. Cotransfection of the α and β subunit cDNAs, but not transfection of α or β alone, was sufficient to reconstitute intercellular adhesion molecule-1 (ICAM-1) binding activity. Consistent with this observation, LFA-1 on the fibroblastoid cells possesses the activation epitope defined by the L16 monoclonal antibody (mAb). This epitope marks the conversion of LFA-1 from the low to high avidity state on peripheral blood T lymphocytes (PBLs) and is constitutively present on activated cell lines. In contrast to LFA-1 on leukocytes, the functional activity of LFA-1 on fibroblastoid cells was not influenced by phorbol ester treatment. Furthermore, the use of agents that interfere with intracellular signaling, a protein kinase C inhibitor, cAMP analogue, or the combination of a phosphodiesterase inhibitor and adenyl cyclase activator, did not affect the binding of COS cells expressing LFA-1 to purified ICAM-1. © 1990 by The American Society for Cell Biology.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 29 条
[1]  
ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175
[2]   ANTI-MAC-1 SELECTIVELY INHIBITS THE MOUSE AND HUMAN TYPE 3 COMPLEMENT RECEPTOR [J].
BELLER, DI ;
SPRINGER, TA ;
SCHREIBER, RD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (04) :1000-1009
[3]   T-CELL RECEPTOR CROSS-LINKING TRANSIENTLY STIMULATES ADHESIVENESS THROUGH LFA-1 [J].
DUSTIN, ML ;
SPRINGER, TA .
NATURE, 1989, 341 (6243) :619-624
[4]  
FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
[5]  
FRIEDRICH W, 1982, BLOOD, V59, P696
[6]  
HIBBS ML, 1990, IN PRESS J CLIN INVE
[7]  
KEIZER GD, 1988, J IMMUNOL, V140, P1393
[8]   THE LEUKOCYTE INTEGRINS [J].
KISHIMOTO, TK ;
LARSON, RS ;
CORBI, AL ;
DUSTIN, ML ;
STAUNTON, DE ;
SPRINGER, TA .
ADVANCES IN IMMUNOLOGY, 1989, 46 :149-182
[9]   CLONING OF THE BETA-SUBUNIT OF THE LEUKOCYTE ADHESION PROTEINS - HOMOLOGY TO AN EXTRACELLULAR-MATRIX RECEPTOR DEFINES A NOVEL SUPERGENE FAMILY [J].
KISHIMOTO, TK ;
OCONNOR, K ;
LEE, A ;
ROBERTS, TM ;
SPRINGER, TA .
CELL, 1987, 48 (04) :681-690
[10]   CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J].
KOHLER, G ;
MILSTEIN, C .
NATURE, 1975, 256 (5517) :495-497